CEimpact Podcast

Remdesivir for COVID-19: The NIAID Study Behind its Approval | GameChangers

Pharmacy Podcast Network Season 11 Episode 1028
Recently, Remdesivir was given Emergency Use Authorization (EUA) status by the U.S. Food and Drug Administration (FDA) for use in COVID based on a heretofore unpublished study. The study, conducted by NIAID,  is the subject of this episode.This episode is accredited for CPE.  For CE details and to claim credit click here:  https://bit.ly/3hn191p See omnystudio.com/listener for privacy information.

Follow CEimpact on Social Media:
LinkedIn
Instagram